Drug Shortage Report for TOBI
Report ID | 192953 |
Drug Identification Number | 02239630 |
Brand name | TOBI |
Common or Proper name | TOBRAMYCIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 56 AMPULES |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-06-01 |
Actual start date | 2023-05-31 |
Estimated end date | 2024-10-01 |
Actual end date | 2024-05-31 |
Shortage status | Resolved |
Updated date | 2024-10-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v57 | 2024-10-04 | French | Compare |
v56 | 2024-10-04 | English | Compare |
v55 | 2024-09-24 | French | Compare |
v54 | 2024-09-24 | English | Compare |
v53 | 2024-09-03 | French | Compare |
v52 | 2024-09-03 | English | Compare |
v51 | 2024-08-12 | French | Compare |
v50 | 2024-08-12 | English | Compare |
v49 | 2024-08-06 | French | Compare |
v48 | 2024-08-06 | English | Compare |
v47 | 2024-07-29 | French | Compare |
v46 | 2024-07-29 | English | Compare |
v45 | 2024-07-23 | French | Compare |
v44 | 2024-07-23 | English | Compare |
v43 | 2024-07-03 | French | Compare |
v42 | 2024-07-03 | English | Compare |
v41 | 2024-06-25 | French | Compare |
v40 | 2024-06-25 | English | Compare |
v39 | 2024-05-17 | French | Compare |
v38 | 2024-05-17 | English | Compare |